IQVIA Holdings | IQV - Operating Expenses


IQVIA Holdings reported $1.77B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Accenture USD 15.54B 7.67M Mar/2026
Agilent USD 1.44B 9M Mar/2026
Bruker USD 768.9M 44.3M Jun/2026
Cardinal Health USD 62.86B 65.69B Jun/2026
Celltrion KRW 119.22B 21.46B Mar/2026
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Cigna USD 42.62B 410M Jun/2026
Cognizant Technology Solutions USD 4.6B 10.46B Jun/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
CVS Health USD 99.37B 3.62B Jun/2026
Danaher USD 52.58B 368M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 47M 22.83M Mar/2026
Divis Laboratories Ltd INR 19.51B 660M Jun/2026
Elevance Health USD 44.88B 981M Jun/2026
Humana USD 39.51B 1.61B Jun/2026
IBM USD 14.72B 18.25B Jun/2026
Illumina USD 899M 47M Jun/2026
Infosys INR 221.9M 370.48B Mar/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Laboratory Of America USD 3.27B 146.9M Jun/2026
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 103.96B 9.5B Jun/2026
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Organigram Holdings CAD 69.59M 14.08M Mar/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pharma Mar EUR 51.01M 8.73M Jun/2026
Publicis EUR 7.58B 51M Jun/2026
Qiagen NV USD 393.64M 17.95M Jun/2026
Quest Diagnostics USD 2.58B 88M Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
Sartorius EUR 747.8M 9.4M Jun/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Tilray USD 237.52M 17.34M Sep/2025
UnitedHealth USD 104.04B 1.36B Jun/2026
Veeva Systems USD 609.84M 19.76M Mar/2026
Veradigm USD 188M 61.08M Dec/2022
Waters USD 527M 592M Jun/2026
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026